产品中心 抗体 其他一抗

所有图片(1/2)

VEGF Receptor 2/FLK-1 Recombinant Rabbit mAb (S-1519-34)

Vascular endothelial growth factor receptor 2,VEGFR-2,Fetal liver kinase 1 (FLK-1),Kinase insert domain receptor (KDR),Protein-tyrosine kinase receptor flk-1,CD309,KDR

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B1138
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    VEGF Receptor/FLK-1
  • 分子别名

    Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1 (FLK-1); Kinase insert domain receptor (KDR); Protein-tyrosine kinase receptor flk-1; CD309; KDR
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane, Cell junction
  • Accession

    P35968
  • 克隆号

    S-1519-34
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu
  • 阳性样本

    HUVEC
  • 预测反应种属
    (反应种属缩写表)

    P. paniscus, P. troglodytes
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

    IP

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu
    IP 1:50 Hu
背景介绍
  • VEGF Receptor 2 (VEGFR2), also known as kinase insert domain receptor (KDR) in humans, is a crucial tyrosine kinase receptor involved in angiogenesis, the formation of new blood vessels. It plays a significant role in various physiological and pathological processes, including development, wound healing, and tumor growth. VEGFR2 is activated upon binding to VEGF (Vascular Endothelial Growth Factor), leading to a series of downstream signaling events that promote endothelial cell proliferation, migration, and survival. This receptor is composed of an extracellular ligand-binding domain, a transmembrane domain, and an intracellular tyrosine kinase domain. Upon VEGF binding, VEGFR2 undergoes dimerization and autophosphorylation, which activates various signaling pathways such as PI3K/Akt, MAPK/ERK, and others.

  • 免疫印迹

    • WB result of VEGF Receptor 2/FLK-1 Recombinant Rabbit mAb
      Primary antibody: VEGF Receptor 2/FLK-1 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: HeLa whole cell lysate 20 µg
      Lane 2: HUVEC whole cell lysate 20 µg
      Negative control: HeLa whole cell lysate
      Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 152 kDa
      Observed MW: 200~260 kDa

  • 免疫沉淀

    • VEGF Receptor 2/FLK-1 Rabbit mAb at 1/50 dilution (1 µg) immunoprecipitating VEGF Receptor 2/FLK-1 in 0.4 mg HUVEC whole cell lysate.
      Western blot was performed on the immunoprecipitate using VEGF Receptor 2/FLK-1 Rabbit mAb at 1/1000 dilution.
      Secondary antibody (HRP) for IP was used at 1/1000 dilution.
      Lane 1: HUVEC whole cell lysate 20 µg (Input)
      Lane 2: VEGF Receptor 2/FLK-1 Rabbit mAb IP in HUVEC whole cell lysate
      Lane 3: Rabbit monoclonal IgG IP in HUVEC whole cell lysate
      Predicted MW: 152 kDa
      Observed MW: 200~260 kDa
      This blot was developed with high sensitivity substrate

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)